Immunoglobulin

Records for this ingredient, by country (identity only).

ATC J06BA01 · 4 markets · 72 records

Immunoglobulin 4 markets · 72 records Forms
Filters
Kind

FR 22 records · 8 shown of 8 Source Base de données publique des médic · Data as of 2026-11-03

Only this ingredient

  • 100 mg/1 mLinjectionCLAIRYG 100 mg/mL, solution pour perfusionFLEBOGAMMA DIF 100 mg/ml, solution pour perfusion、GAMUNEX 100 mg/mL, solution pour perfusion、HYQVIA 100 mg/mL, soution pour perfusion par voie sous-cutanée、INTRATECT 100 g/L, solution pour perfusion、KIOVIG 100 mg/ml, solution pour perfusion、OCTAGAM 100 mg/ml, solution pour perfusion、PRIVIGEN 100 mg/ml, solution pour perfusion
  • 50 mg/1 mLinjectionCLAIRYG 100 mg/mL, solution pour perfusionFLEBOGAMMA DIF 100 mg/ml, solution pour perfusion、GAMMAGARD 50 mg/ml, poudre et solvant pour solution pour perfusion、INTRATECT 100 g/L, solution pour perfusion、OCTAGAM 100 mg/ml, solution pour perfusion、TEGELINE 50 mg/mL, poudre et solvant pour solution pour perfusion
  • 200 mg/1 mLinjectionCUVITRU 200 mg/ml, solution injectable par voie sous-cutanéeHIZENTRA 200 mg/ml, solution injectable sous-cutanée、XEMBIFY 200 mg/mL, solution injectable sous-cutanée
  • 5,000 IU/100 mLinjectionIVHEBEX 5000 UI/100 mL, poudre et solvant pour solution pour perfusion
  • 500 IU/1 mLinjectionZUTECTRA 500 UI, solution injectable en seringue préremplie
  • 250 IU/2 mLinjectionGAMMATETANOS 250 UI/2 mL, solution injectable (IM)
  • 165 mg/1 mLinjectionCUTAQUIG 165 mg/mL, solution injectable
  • 100 IU/1 mLinjectionIMMUNOGLOBULINE HUMAINE DE L'HEPATITE B LFB 100 UI/mL, solution injectable en seringue préremplie (IM)

CA 20 records · 9 shown of 9 Source Health Canada Drug Product Databas · Data as of 2026-10-23

Only this ingredient

  • 200 mg per mL / per unit basis not statedliquidCUVITRUHIZENTRA
  • 100 mg/1 mLliquidGAMUNEXIGIVNEX
  • 50 mg per mL / per unit basis not statedliquidFLEBOGAMMAOCTAGAM
  • 10 % per mL / per unit basis not statedliquidGAMMAGARDPRIVIGEN
  • 5,000 mg per mL / per unit basis not statedliquidGAMMAGARD S/D
  • 100 mg per mL / per unit basis not statedliquidFLEBOGAMMA
  • 20 % per mL / per unit basis not statedliquidXembify
  • 18 % per mL / per unit basis not statedliquidGAMASTAN

Combination products containing this ingredient

  • 100 mg/1 mLliquid CombinationHyaluronidase (Human Recombinant) 160 unit/1 mL + Immunoglobulin 100 mg/1 mLHYQVIA

SG 7 records · 1 shown of 1 Source Health Sciences Authority (HSA) · Data as of 2026-08-07 · some records have no stated strength

Only this ingredient

  • 50 mg/mL per mL / per unit basis not statedinjectionOCTAGAM SOLUTION FOR INFUSION 50 mg/mlPENTAGLOBIN INJECTION 50 mg/ml
5 records · 0 manufacturers 5 registros · 0 fabricantes 5 个记录 · 0 个厂家 5 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名GRAFALON 20 mg/ml ×1HIZENTRA SOLUTION FOR SUBCUTANEOUS INJECTION 200g/L ×1IGANTET INJECTION 250 iu/ml ×1IGANTET INJECTION 500 iu/2 ml ×1PRIVIGEN SOLUTION FOR INFUSION 100g/L ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

AU 3 records · 0 shown of 0 Source TGA CMI repository (consumer medic · Data as of live · some records have no stated strength · includes records with unknown status (not proof of sale)

3 records · 0 manufacturers 3 registros · 0 fabricantes 3 个记录 · 0 个厂家 3 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名CMV Immunoglobulin-VF ×1Hepatitis B Immunoglobulin-VF ×1Tetanus Immunoglobulin-VF (for intravenous use) ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.